Joe Henein, President & CEO, NewBridge Pharmaceuticals is attending the
12th International Pharmaceutical and Medical Device Compliance Congress from 14th to 16th May, 2018 in Vienna, Austria. Joe – as one of the featured faculty of the congress – is moderating a mini summit session entitled the
“Annual Middle East Africa (MEA) Compliance Update” with panelists from the MEA region.